Medicare Enrolled

Dr. Vladan Milosavljevic, M.D.

Neurology · Lawrence, MA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
354 MERRIMACK ST, Lawrence, MA 01843
9786872321
In practice since 2005 (20 years)
NPI: 1982691655 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Milosavljevic from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Milosavljevic? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Milosavljevic

Dr. Vladan Milosavljevic is a neurology specialist in Lawrence, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Milosavljevic performed 1,721 Medicare services across 1,149 unique beneficiaries.

Between the years covered by Open Payments, Dr. Milosavljevic received a total of $106,849 from 69 pharmaceutical and/or device companies across 1786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Milosavljevic is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 9% volume in MA $106,849 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,721
Medicare services
Top 9% in MA for neurology
1,149
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
534 $68 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
445 $100 $228
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
182 $81 $184
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
135 $129 $302
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
130 $45 $156
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
92 $308 $850
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
49 $175 $403
New patient office visit, complex (60-74 min) 43 $163 $385
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
33 $235 $518
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
32 $53 $120
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
30 $145 $330
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $138 $308
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$106,849
Total received (2018-2024)
Avg $15,264/year across 7 years
Top 7% in MA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
1,786
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72,980 (68.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,334 (30.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,535 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25,150
2023
$19,896
2022
$20,466
2021
$13,122
2020
$12,129
2019
$5,849
2018
$10,238

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$12,632
ABBVIE INC.
$7,461
LivaNova USA, Inc.
$1,834
EMD Serono, Inc.
$571
ANI Pharmaceuticals, Inc.
$333
IRONSHORE PHARMACEUTICALS INC.
$329
Kyowa Kirin, Inc.
$237
Tris Pharma Inc
$200
PFIZER INC.
$192
Teva Pharmaceuticals USA, Inc.
$184
Neurelis, Inc.
$179
Biogen, Inc.
$156
Novartis Pharmaceuticals Corporation
$141
Neos Therapeutics, LP
$106
Neurocrine Biosciences, Inc.
$106
Amneal Pharmaceuticals LLC
$102
Merz Pharmaceuticals, LLC
$91
Lundbeck LLC
$68
MITSUBISHI TANABE PHARMA AMERICA, INC.
$65
Lilly USA, LLC
$38
MDD US Operations, LLC
$37
ARGENX US, INC.
$25
ACADIA Pharmaceuticals Inc
$21
Otsuka America Pharmaceutical, Inc.
$19
AstraZeneca Pharmaceuticals LP
$15
Life Molecular Imaging Ltd
$10
Top 3 companies account for 87.2% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$32,852
ABBVIE INC.
$27,343
Allergan, Inc.
$11,611
AbbVie Inc.
$8,492
LivaNova USA, Inc.
$6,152
Amneal Pharmaceuticals LLC
$1,820
Novartis Pharmaceuticals Corporation
$1,784
Teva Pharmaceuticals USA, Inc.
$1,382
EMD Serono, Inc.
$1,294
Kyowa Kirin, Inc.
$1,114
Neos Therapeutics, LP
$828
Lundbeck LLC
$781
UCB, Inc.
$554
Biogen, Inc.
$509
Ironshore Pharmaceuticals Inc.
$503
Sunovion Pharmaceuticals Inc.
$502
Neurocrine Biosciences, Inc.
$493
Mallinckrodt Enterprises LLC
$476
Shire North American Group Inc
$467
Avanir Pharmaceuticals, Inc.
$461
ANI Pharmaceuticals, Inc.
$437
Janssen Pharmaceuticals, Inc
$427
Tris Pharma Inc
$427
Adamas Pharmaceuticals, Inc.
$347
IRONSHORE PHARMACEUTICALS INC.
$329
Neurelis, Inc.
$317
Allergan Inc.
$317
SK Life Science, Inc.
$294
Ipsen Biopharmaceuticals, Inc
$290
Amgen Inc.
$281
Mallinckrodt LLC
$272
PFIZER INC.
$251
Biohaven Pharmaceutical Holding Company Ltd.
$245
Eisai Inc.
$239
Acorda Therapeutics, Inc
$226
Alexion Pharmaceuticals, Inc.
$226
Biohaven Pharmaceuticals, Inc.
$186
MDD US Operations, LLC
$172
Celgene Corporation
$164
MITSUBISHI TANABE PHARMA AMERICA, INC.
$158
GENZYME CORPORATION
$147
ACADIA Pharmaceuticals Inc
$139
Exeltis, USA Inc.
$131
Lilly USA, LLC
$120
Mallinckrodt Hospital Products Inc.
$115
Genentech, Inc.
$109
ARGENX US, INC.
$102
Mitsubishi Tanabe Pharma America, Inc.
$99
Merz Pharmaceuticals, LLC
$91
E.R. Squibb & Sons, L.L.C.
$91
Genentech USA, Inc.
$71
Avion Pharmaceuticals
$62
Greenwich Biosciences, Inc.
$60
EISAI INC.
$54
GE HEALTHCARE
$51
Corium, LLC
$45
Alnylam Pharmaceuticals Inc.
$44
Vertical Pharmaceuticals, LLC
$44
AstraZeneca Pharmaceuticals LP
$40
Otsuka America Pharmaceutical, Inc.
$36
Akcea Therapeutics, Inc.
$32
GE HealthCare
$30
Banner Life Sciences, LLC
$21
Impax Laboratories, Inc.
$19
Sumitomo Pharma America, Inc.
$17
Jazz Pharmaceuticals Inc.
$16
Grifols USA, LLC
$16
GE Healthcare
$13
Life Molecular Imaging Ltd
$10
Top 3 companies account for 67.2% of all-time payments
Associated products mentioned in payments ›
3-T Heater-Cooler System · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · Apokyn · Austedo XR · Azstarys · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Briviact · COPAXONE · COTEMPLA XR-ODT · DYSPORT · Dhivy · Dyanavel XR · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · Fycompa · GILENYA · GOCOVRI · Gamunex-C · INBRIJA · INGREZZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · MAVENCLAD · MAYZENT · MYDAYIS · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QULIPTA · Qelbree · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SKYCLARYS · SOLIRIS · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · Vimpat · WAINUA · XCOPRI · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in MA.

Looking for a neurology specialist in Lawrence?
Compare neurologists in the Lawrence area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
605
Per 100K population
74.9
County median income
$99,431
Nearest hospital
HOLY FAMILY HOSPITAL
3.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Milosavljevic is a clinical cardiology specialist, with above-average Medicare volume (top 9% in MA), with speaking/promotional industry engagement in the top 7% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Milosavljevic experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Milosavljevic performed 534 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Milosavljevic receive payments from pharmaceutical companies?
Yes. Dr. Milosavljevic received a total of $106,849 from 69 companies across 1,786 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Milosavljevic's costs compare to other neurologists in Lawrence?
Dr. Milosavljevic's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Milosavljevic) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →